San Francisco Partner Judith Waltz was quoted in an article titled “Sunshine Act Compliance Stymies Healthcare Firms” in the July 2013 issue of Compliance Week. The article discusses the impact the Sunshine Act will have on drug companies and medical equipment companies. Ms. Waltz was quoted saying, “This may relate to concerns about how their participation will be viewed by patients, or to the increasing prevalence of institutional policies that limit or even preclude involvement in any activity that might be viewed as a conflict of interest for clinical decision making. [If this trend continues,] it could result in some significant constrictions on future research and clinical discussion of existing drugs.”
People
Related News
18 October 2024
In the News
Samuel Goldstick Discusses Emerging Cybersecurity Concerns for Connected Vehicles
Foley & Lardner LLP senior counsel Samuel Goldstick offered insight on the growing regulatory scrutiny on connected vehicles in the Automotive Dive article, "The auto industry’s cybersecurity challenges are mounting, experts say."
18 October 2024
In the News
Mark Neuberger on FLSA Overtime Exemption Salary Increase – 'Employers should institute guardrails'
Foley & Lardner LLP of counsel Mark Neuberger described how employers should prepare for the approaching second increase to Fair Labor Standards Act's salary level for overtime exemption in the Law360 article, "3 Tips To Manage Salary Level Increase Under FLSA Rule."
17 October 2024
In the News
Donald Schroeder on Trade Secrets Suit – 'This is why noncompetes exist'
Foley & Lardner LLP partner Donald Schroeder is quoted in the Law360 article, "Industrial Pipe Co. Hits Rival, Ex-Exec With Trade Secrets Suit."